Notably, Chk1 inhibitors used in the present study including SB218078 and PF477736 could reduce the DNA damage in neurons instead of increasing DNA damage in tumor cells, which was manifested by decreased γH2A.X level, indicating different therapeutic mechanisms of Chk1 inhibition in tumor and neurodegeneration. The gene discussed is CHEK1; the disease is neoplasm.